Identifying Hyperglycaemia in Overweight and Obese Adolescents
To Identify Anytime Hyperglycaemia in Subjects With Normoglycaemia and Prediabetes
Diabetes Foundation, India · NCT05939895
This study is testing how continuous glucose monitoring can help overweight and obese teenagers understand their blood sugar levels and how they relate to other tests for diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 30 Years to 60 Years |
| Sex | All |
| Sponsor | Diabetes Foundation, India (other) |
| Locations | 1 site (New Delhi, Delhi) |
| Trial ID | NCT05939895 on ClinicalTrials.gov |
What this trial studies
This observational study aims to recruit 100 overweight and obese adolescents with varying levels of HbA1c, from normal to prediabetes. Participants will undergo continuous glucose monitoring (CGM) to assess their glucose levels in a free-living environment. The study will also evaluate the relationships between CGM outcomes, HbA1c levels, and oral glucose tolerance test (OGTT) results. Data will be collected during two visits to the Fortis CDOC Hospital after an overnight fast, with informed consent obtained in a language understood by the participants.
Who should consider this trial
Good fit: Ideal candidates for this study are overweight and obese adolescents aged 30-60 years with a BMI between 23-35 kg/m2.
Not a fit: Patients with overt diabetes or those with conditions such as hypothyroidism, substantial alcohol consumption, or current smoking may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection and prevention strategies for type 2 diabetes in adolescents.
How similar studies have performed: Other studies have shown success in using continuous glucose monitoring to identify glucose abnormalities in similar populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age -30-60 yrs 2. BMI- \>23- 35Kg/m2 Exclusion Criteria: 1. Hypothyroidism on treatment. 2. Substantial alcohol consumption (\>20 g/day for women or \>30 g/day for men). 3. Current smoker 4. Concomitant confounding drug use (steroid, vit E)
Where this trial is running
New Delhi, Delhi
- Fortis CDOC Hospital — New Delhi, Delhi, India (RECRUITING)
Study contacts
- Principal investigator: AMRITA GHOSH, MBBS — Fortis CDOC Hospital
- Study coordinator: ANOOP MISRA, MD
- Email: anoopmisra@gmail.com
- Phone: 01149101222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Healthy, Non Diabetic, Prediabetes